Which Rapid Phenotypic Antimicrobial Susceptibility Tests Truly Reach Point-Of-Care?

By Priyanka Manohar

EMS300 Student Conference 2026

Slide 1: Which rapid phenotypic antimicrobial susceptibility tests truly reach point-of-care?. A full description follows.

Summary

The presentation evaluates rapid phenotypic antimicrobial susceptibility tests against the REASSURED criteria, aiming to determine which tests can effectively reach point-of-care settings. Key findings indicate that no technology fully meets all REASSURED criteria, highlighting gaps in treatment decision-making and susceptibility results. The presentation includes a heatmap and a tiered framework to illustrate these findings and proposes using REASSURED as both a checklist and a design tool for future developments. The audience likely comprises healthcare professionals and researchers interested in antimicrobial resistance and diagnostic testing.